Related Experiment Video

Updated: May 26, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

An oligopeptide ligand-mediated therapeutic gene nanocomplex for liver cancer-targeted therapy

M Liu1, Z H Li, F J Xu

  • 1Institute of Chemical Biology and Pharmaceutical Chemistry, Zhejiang University, Hangzhou 310028, PR China.

Biomaterials
|December 20, 2011
PubMed

Insights

New EGFR-targeted gene carriers effectively deliver the acetylcholinesterase gene (AChE gene) to liver cancer cells, suppressing proliferation. This novel approach shows promise for treating EGFR-positive liver cancers.

Area of Science:

  • Oncology
  • Gene Therapy
  • Biotechnology

Background:

  • Epidermal growth factor receptor (EGFR) is over-expressed in many epithelial cancers, including liver cancer.
  • Targeting EGFR offers a potential strategy for cancer treatment.
  • Gene therapy aims to introduce genetic material to treat diseases.

Purpose of the Study:

  • To design and evaluate EGFR-targeted gene carriers for liver cancer treatment.
  • To complex the acetylcholinesterase gene (AChE gene) with targeted vectors.
  • To assess the efficacy of these vectors in delivering the AChE gene to EGFR-positive liver cancer cells.

Main Methods:

  • Constructed EGFR-targeted gene vectors (YPCs) by coupling YC21 ligand to PEI(600)-CD (PC) vectors.
  • Formulated YPC/AChE gene complexes.
  • Evaluated gene delivery and transfection efficiency in EGFR-positive liver cancer cells in vitro and in vivo.

Main Results:

  • YPC vectors demonstrated highly efficient gene delivery to EGFR-positive liver cancer cells.
  • YPCs effectively promoted AChE gene expression.
  • YPC/AChE complexes exhibited excellent gene transfection abilities in vitro and in vivo.

Conclusions:

  • EGFR-targeted gene vectors (YPCs) are effective in delivering the AChE gene to EGFR-positive liver cancer cells.
  • The YPC/AChE complexes show significant potential for the treatment of EGFR-positive liver cancers.
  • This targeted gene delivery system offers a promising therapeutic strategy for liver cancer.

More Related Videos

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...